CYBeR-CARE Announces FDA Approval For Blood Glucose Monitoring System - Glucometer.Business Editors and Health/Medical Writers ATLANTA--(BW HealthWire)--Dec. 28, 2000 CYBeR-CARE, Inc. (Nasdaq:CYBR CYBR Copy Byte Right ), the telehealth technology innovator, recently received clearance from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. to market its Blood Glucose Monitoring blood glucose monitoring Sugar monitoring Lab medicine The periodic testing of serum glucose in Pts known to have DM. See Bedside glucose monitoring, Beta cell implants, Diabetes, Glucometer, Glycosylated hemoglobin, Non-Invasive glucose monitoring. System (Glucometer). The Glucometer will be integrated with the Electronic HouseCall(TM) System family of products and will provide the industry with an economically priced tool with several technological advantages over current industry offerings. Packet technology benefits system users by simultaneously transmitting data received from the Glucometer along with voice and visual information. All information is received in real-time by the caregiver and is available to payors and caregivers through the secure CYBeR-CARE network. Caregivers can measure results against historical data, from the Glucometer and other monitoring tools available on the Electronic HouseCall System to enable them to deliver better care and more effective disease management treatment. "We are pleased to be able to announce the FDA approval for our electronic Blood Glucose Monitoring System," said Mike Lemnitzer, Vice President of Business Development, CyberCare Technologies. "This tool significantly expands our target market by allowing the at home remote monitoring (protocol) remote monitoring - (RMON) A network management protocol that allows network information to be gathered at a single computer. Whereas SNMP gathers network data from a single type of Management Information Base (MIB), RMON 1 defines nine additional MIBs that provide a of the diabetic patient." According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the American Diabetes Association The American Diabetes Association, or the ADA, is an American health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of , there are 15.7 million diabetics in the U.S., of which 5.4 million are undiagnosed. The product underwent clinical trials at the nationally renowned Shepherd Center, a specialty hospital located in Atlanta, and will be available for shipment in January. About CYBeR-CARE, Inc. CyberCare Technologies is a subsidiary of CYBeR-CARE, Inc. Based in Boynton Beach, FL, CYBeR-CARE is a network company with a patented Internet-based technology system that provides for the remote monitoring of individuals for health care purposes. The Company also has physical, occupational and speech therapy centers and an institutional pharmacy. CYBeR-CARE can be found on the Web at http://www.cyber-care.net. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion